PHASE-I TRIAL AND PHARMACOKINETIC EVALUATION OF FAZARABINE IN CHILDREN

被引：0
|
作者：
HEIDEMAN, RL
GILLESPIE, A
FORD, H
REAMAN, GH
BALIS, FM
TAN, C
SATO, J
ETTINGER, LJ
PACKER, RJ
POPLACK, DG
机构：
[1] NCI,PEDIAT BRANCH,BLDG 10,ROOM 13N 240,BETHESDA,MD 20892
[2] NCI,MED CHEM LAB,BETHESDA,MD 20892
[3] CHILDRENS HOSP,NATL MED CTR,WASHINGTON,DC 20010
[4] MEM SLOAN KETTERING CANC CTR,NEW YORK,NY 10021
[5] CHILDRENS HOSP LOS ANGELES,LOS ANGELES,CA 90054
[6] UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,NEW BRUNSWICK,NJ 08903
[7] CHILDRENS HOSP PHILADELPHIA,PHILADELPHIA,PA 19104
来源：
CANCER RESEARCH | 1989年 / 49卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5213 / 5216
页数：4
相关论文
共 50 条
  • [21] PHASE-I PHARMACOKINETIC REEVALUATION OF THIOTEPA
    ODWYER, PJ
    LACRETA, F
    ENGSTROM, PF
    PETER, R
    TARTAGLIA, L
    COLE, D
    LITWIN, S
    DEVITO, J
    POPLACK, D
    DELAP, RJ
    COMIS, RL
    CANCER RESEARCH, 1991, 51 (12) : 3171 - 3176
  • [22] A PHASE-I AND PHARMACOKINETIC STUDY OF AMPHETHINILE
    SMITH, DB
    EWEN, C
    MACKINTOSH, J
    FOX, BW
    THATCHER, N
    SCARFFE, JH
    VEZIN, R
    CROWTHER, D
    BRITISH JOURNAL OF CANCER, 1988, 57 (06) : 623 - 627
  • [23] PHASE-I AND PHARMACOKINETIC STUDIES OF DON
    KOVACH, JS
    EAGAN, RT
    POWIS, G
    RUBIN, J
    CREAGAN, ET
    MOERTEL, CG
    CANCER TREATMENT REPORTS, 1981, 65 (11-1): : 1031 - 1036
  • [24] PHASE-I AND PHARMACOKINETIC STUDY OF RHIZOXIN
    BISSETT, D
    GRAHAM, MA
    SETANOIANS, A
    CHADWICK, GA
    WILSON, P
    KOIER, I
    HENRAR, R
    SCHWARTSMANN, G
    CASSIDY, J
    KAYE, SB
    KERR, DJ
    CANCER RESEARCH, 1992, 52 (10) : 2894 - 2898
  • [25] PHASE-I STUDY OF 5-AZACYTOSINE ARABINOSIDE (ARA-AC, FAZARABINE)
    AMATO, R
    RABER, M
    NEWMAN, R
    HO, D
    SCHMIDT, S
    MCKELVEY, E
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 194 - 194
  • [26] PHARMACOKINETIC AND BIOTRANSFORMATION STUDIES OF ORMAPLATIN IN CONJUNCTION WITH A PHASE-I CLINICAL-TRIAL
    PETROS, WP
    CHANEY, SG
    SMITH, DC
    FANGMEIER, J
    SAKATA, M
    BROWN, TD
    TRUMP, DL
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1994, 33 (04) : 347 - 354
  • [27] PHASE-I TRIAL AND PHARMACOKINETIC STUDY OF INTRAVENOUS AND ORAL ALPHA-DIFLUOROMETHYLORNITHINE
    GRIFFIN, CA
    SLAVIK, M
    CHIEN, SC
    HERMANN, J
    THOMPSON, G
    BLANC, O
    LUK, GD
    BAYLIN, SB
    ABELOFF, MD
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (02) : 177 - 186
  • [28] PHASE-I CLINICAL AND PHARMACOKINETIC TRIAL OF FLAVONE ACETIC-ACID (FAA)
    HAVLIN, K
    CRAIG, J
    KUHN, J
    BOLDT, D
    WEISS, G
    KOELLER, J
    HARMAN, G
    CLARK, G
    VONHOFF, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 221 - 221
  • [29] PHASE-I TRIAL AND PHARMACOKINETIC STUDY OF 5'-DEOXY-5-FLUOROURIDINE
    ABELE, R
    ALBERTO, P
    SEEMATTER, RJ
    HEINTZ, R
    GERMANO, G
    WEBER, W
    OBRECHT, JP
    CANO, JP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 178 - 178
  • [30] PHASE-I CLINICAL-TRIAL WITH PHARMACOKINETIC AND IMMUNOLOGICAL STUDY OF ACODAZOLE HCL
    GREM, J
    TRUMP, DL
    KOELLER, J
    BORDEN, EC
    TORMEY, DC
    CLINICAL RESEARCH, 1984, 32 (04): : A765 - A765
12345